Pulsed-field ablation versus conventional thermal ablation for atrial fibrillation: a meta-analysis of randomised controlled trials
European Heart Journal

Abstract
Pulsed-field ablation is a novel ablation technique using non-thermal energy. Although several studies have reported the efficacy and safety of pulsed-field ablation for atrial fibrillation, results from randomised controlled trials (RCTs) are limited.
The aim of this study was to compare pulsed-field ablation with conventional thermal ablation in patients with atrial fibrillation.
We conducted a meta-analysis of RCTs. PubMed, the Cochrane Central Register of Controlled Trials, the web of science, and
A total of 906 patients in 4 RCTs were included in this study. Pulsed-field ablation significantly reduced total procedure time compared with conventional thermal ablation (mean difference (MD) -55.04 min.; 95% confidence interval (CI) [-92.74, -17.35]; p = 0.004). On the other hand, fluoroscopy time (MD 3.51 min.; 95% CI [-2.07, 9.08]; p = 0.22) recurrence of atrial arrhythmia (odds ratio (OR) 0.51; 95% CI [0.17, 1.51]; p = 0.23), and occurrence of complications (OR 0.80; 95% CI [0.32, 2.05]; p = 0.65) were similar between the 2 groups.
In patients with atrial fibrillation, pulsed-field ablation may be associated with reduction in total procedure time, but not fluoroscopy time, recurrent atrial arrhythmia, or complications as compared with conventional thermal ablation. Further large-scale RCTs are warranted to validate the efficacy and safety of pulsed-field ablation.
Contributors

R Sakurai
Author
Graduate School of Public Health, International University of Health and Welfare Tokyo , Japan



